Trial Profile
Alemtuzumab with corticosteroid minimization for pediatric deceased donor renal transplantation.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Dec 2015
Price :
$35
*
At a glance
- Drugs Alemtuzumab (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 27 Dec 2015 New trial record